DEUTSCHE BANK AG\ - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 38 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$78,000
-13.3%
10,714
-8.6%
0.00%
Q4 2020$90,000
+40.6%
11,721
+66.5%
0.00%
Q3 2020$64,000
+16.4%
7,040
+9.1%
0.00%
Q2 2020$55,000
+292.9%
6,455
+126.7%
0.00%
Q1 2020$14,000
-63.2%
2,847
-48.3%
0.00%
Q4 2019$38,000
+58.3%
5,503
+128.5%
0.00%
Q3 2019$24,000
-71.1%
2,408
-63.1%
0.00%
Q2 2019$83,000
-16.2%
6,526
-36.1%
0.00%
Q1 2019$99,000
-13.9%
10,212
-8.7%
0.00%
Q4 2018$115,00011,1880.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Orbimed Advisors 6,466,783$69,906,0001.33%
Board of Trustees of The Leland Stanford Junior University 949,443$10,264,0001.11%
Lion Point Capital, LP 500,000$5,405,0000.60%
Sio Capital Management, LLC 122,536$1,325,0000.43%
Redmile Group, LLC 749,026$8,097,0000.27%
SAMLYN CAPITAL, LLC 639,977$6,918,0000.17%
Stanley-Laman Group, Ltd. 19,530$211,0000.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,378,475$14,901,0000.04%
FRANKLIN RESOURCES INC 700,000$7,567,0000.00%
Jefferies Group LLC 10,618$115,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders